Novo Nordisk said it achieved 200,000 weekly prescription in the U.S. for the Wegovy pill by mid-April, which it said was the fastest take-up ever in the GLP-1 category of drugs in the U.S., which ...

Inflows to dividend ETFs came just in time for dividend stocks to lag amid a rebound in the broad equity market. In April, ...

We own our home, which is paid off.' "We were considering a VA loan, to have the funds for updates without touching our CD or money-market fund." (Photo subjects are models.) Dear Quentin, My husband ...

Lazard Asset Management expects a renewed steepening of the government bond yield curve , particularly in the eurozone. This would be a logical consequence of ambitious fiscal programs, tight labor ...

Electronic Arts has agreed to go private in 2026, and we expect the firm to receive the necessary regulatory approvals.

Dow Jones Top Energy Headlines at 4 AM ET: Orsted's Earnings Rise on Jump in Offshore Generation | This ... The renewable-energy company's earnings before interest, taxes, depreciation and ...

The maximum Social Security check at full retirement age (67) is already $4,152 per month (or $49,824 a year) for 2026. The only way to go above this is to claim at age 70 for a maximum of $5,181 per ...

We see Sumitomo's strategy as built around stable, recurring earnings through a diversified portfolio spanning infrastructure, leasing, real estate, industrial equipment, and trading. The non-resource ...

The core network services business remains in decline, however, as the cost of capacity declines amid a tough competitive environment. Transparency is how we protect the integrity of our work and keep ...

Diageo isn't the only booze seller grappling with a tough market. French spirits company Pernod Ricard said last month it anticipates a 3% to 4% decline in net sales for the year, which it said was ...

In Europe, the Stoxx Europe 600 gained 1.2% in morning trading. Demant rose 14.3% and Amplifon added 13.1%. On the other hand, Alcon sunk 8.6%, and Wolters Kluwer lost 7.9%. The FTSE 100 added 1.5%.

Novo Nordisk said it achieved 200,000 weekly prescription in the U.S. for the Wegovy pill by mid-April, which it said was the fastest take-up ever in the GLP-1 category of drugs in the U.S., which ...